Risk factors
Myomo (MYO) risk factors
Item 1A of every Myomo, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors60 risks7 new4 dropped19 reworded
Operating losses worsened significantly to $15.6 million in 2025, driven by higher R&D and advertising costs. New debt covenants with Avenue restrict operations and require maintaining $2.5 million in cash. Medicare Advantage authorizations declined, and social media algorithm changes increased lead generation costs.
Filed Mar 09, 2026 - FY2024 10-K risk factors57 risks
Myomo faces ongoing operating losses with an accumulated deficit of $103.1 million, while relying heavily on direct billing and Medicare Advantage reimbursement for its MyoPro device.
Filed Mar 10, 2025